Kane Biotech Inc Cash Flow Reinvestment Rate
Latest as of June 2023:
0.31x
Kane Biotech Inc cash flow reinvestment rate. Kane Biotech Inc (KNE) has a Cash Flow Reinvestment Rate of 0.31x as of June 2023, reinvesting CA$117.30K (capex CA$58.65K plus investments CA$-58.65K) from operating cash flow of CA$382.38K. Explore KNE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.31x
(Capex + Investments) / Operating CF
Total Reinvested
CA$117.30K
Capex + Investments
Operating Cash Flow
CA$382.38K
CAD
Capital Expenditures
CA$58.65K
CAD
Kane Biotech Inc Cash Flow Reinvestment Rate by Year (None–None)
Kane Biotech Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Kane Biotech Inc. For the full cash flow conversion analysis, see KNE operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow